Article
EyeGate Pharma’s broad iontophoresis patent portfolio for corneal collagen cross-linking will be held as exclusive license by Avedro Inc. Delivery approach provides potential additional benefits to current formulation.
A history of the femtosecond laser in the United States and Europe
Week in Review - October 5, 2024
Factors affecting ROP development in the 8 weeks following birth
Innovation Series: AI’s impact on managing ocular surface disease with Peter J. McDonnell, MD, and Laura M. Periman, MD
First patient dosed in clinical trial to treat neuropathic corneal pain
The top 10 takeaways from AAO 2024